Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA

Journal of Clinical Microbiology

Volumn 40, Issue 7, 2002, Pages 2408-2419

  Giachetti, C ^a   Linnen, J M ^a   Kolk, D P ^a   Dockter, J ^a   Gillotte Taylor, K ^a   Park, M ^a   Ho Sing Loy, M ^a   McCormick, M K ^a   Mimms, L T ^a   McDonough, S H ^a  

^a Gen Probe Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANALYTIC METHOD; ARTICLE; AUTOMATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYBRIDIZATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

BLOOD DONORS; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MASS SCREENING; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036301740     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.7.2408-2419.2002     Document Type: Article

References (45)

1. Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2
2. Genomic screening for blood-borne viruses in transfusion settings
3. Will genome detection replace serology in blood screening for microbial agents?
4. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
5. Assay formats involving acridinium-ester-labeled DNA probes
6. HIV and blood transfusions: Focus on seroconversion
7. Testing blood donors for HIV: Current controversies
8. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors
9. Transfusion-transmitted AIDS with blood negative for anti-HIV and HIV-antigen
10. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml
11. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma
12. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma
13. Hepatitis C virus antibodies among risk groups in Spain
14. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis
15. Blood screening by nucleic acid amplification technology: Current issues, future challenges
16. High throughput assay for sensitive detection of HIV-1 RNA of diverse origins, including type O strains
17. Diagnostic tests for hepatitis C
18. Assessment of hepatitis C viremia using molecular amplification technologies: Correlations and clinical implications
19. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection
20. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes
21. Significant closure of the HIV-1 and HCV preseroconversion detection windows with a TMA-driven HIV-1/HCV assay
22. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
23. The ligase chain reaction in DNA-based diagnosis
24. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: Calibration to international units, enhanced genotype reactivity, and performance characteristics
25. Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on Transcription-Mediated Amplification
26. Detection of HCV RNA by the asymmetric gap ligase chain reaction
27. High throughput assay for the simultaneous or separate detection of human immunodeficiency virus (HIV) and hepatitis type C virus (HCV)
28. A rapid and sensitive method for non-isotopic quantitation of HIV-1 RNA using thermophilic strand displacement amplification and flow cytometry
29. Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2
30. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection
31. Simultaneous detection of multiple nucleic acid targets in a homogeneous format
32. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma
33. Virologic parameters as surrogate markers for clinical outcome in HIV-1 disease: Verification, variation, and validation
34. Calibration of HCV working reagents for NAT assays against the HCV international standard
35. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors
36. NAT of the United States and Canadian blood supply
37. Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood
38. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology
39. Quantification of HIV-1 RNA in plasma: Comparable results with the nucleic acid sequence-based amplification HIV-1 RNA QT and the AMPLICOR HIV monitor test
40. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands
41. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification
42. Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA
43. Strand displacement amplification-an isothermal, in vitro DNA amplification technique
44. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test